塞利洛尔：对哮喘患者中一种新型β1、α2肾上腺素能受体拮抗剂的研究。 - Suppr

Suppr

超能文献

Celiprolol: an investigation of a new beta 1-, alpha 2-adrenoceptor antagonist in asthmatic patients.

作者信息

Rosenthal R R, Doshan H D, Applin W J, Caruso F S

出版信息

Br J Clin Pract Suppl. 1985 Jun;40:34-6.

PMID:2864060

Abstract

摘要

相似文献

Celiprolol: an investigation of a new beta 1-, alpha 2-adrenoceptor antagonist in asthmatic patients.塞利洛尔：对哮喘患者中一种新型β1、α2肾上腺素能受体拮抗剂的研究。

Br J Clin Pract Suppl. 1985 Jun;40:34-6.

Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.

Eur Respir J. 1992 Feb;5(2):196-200.

Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.新型β1、α2受体阻滞剂塞利洛尔对普萘洛尔敏感的哮喘患者的支气管保护特性

J Cardiovasc Pharmacol. 1986;8 Suppl 4:S40-2.

Celiprolol: a haemodynamic appraisal in comparison with propranolol.塞利洛尔：与普萘洛尔相比的血流动力学评估。

Br J Clin Pract Suppl. 1985 Jun;40:43-4.

The cardiopulmonary effects of celiprolol and propranolol in asymptomatic bronchial asthmatics.塞利洛尔和普萘洛尔对无症状支气管哮喘患者的心肺效应

Br J Clin Pract Suppl. 1985 Jun;40:33.

Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients.塞利洛尔在哮喘患者和老年患者中的临床剂量、疗效及安全性。

Br J Clin Pract Suppl. 1985 Jun;40:25-32.

The bronchosparing effect of celiprolol, a new beta 1- alpha 2-receptor antagonist on pulmonary function of propranolol-sensitive asthmatics.

J Clin Pharmacol. 1985 Jul-Aug;25(5):354-9. doi: 10.1002/j.1552-4604.1985.tb02854.x.

Mechanistic studies on the "bronchosparing" activity of celiprolol, a cardioselective beta-adrenoceptor antagonist.塞利洛尔（一种心脏选择性β-肾上腺素能受体拮抗剂）“支气管 sparing”活性的机制研究

Arch Int Pharmacodyn Ther. 1986 Nov;284(1):127-44.

Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.塞利洛尔，一种强效的心脏选择性β1肾上腺素能受体拮抗剂，具有轻度的α2肾上腺素能受体拮抗特性。

J Hypertens Suppl. 1985 Dec;3(3):S195-7.

[Inhibitory effect of alpha-2 adrenoceptor antagonist (DG-5128) on intractable asthma].α-2肾上腺素能受体拮抗剂（DG-5128）对难治性哮喘的抑制作用

Arerugi. 1987 Jul;36(7):413-6.

引用本文的文献

Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.塞利洛尔：对其治疗高血压和心绞痛的药理特性及临床疗效的评估

Drugs Aging. 1995 Nov;7(5):394-411. doi: 10.2165/00002512-199507050-00006.

A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.塞利洛尔治疗心血管疾病的风险效益评估。

Drug Saf. 1994 Mar;10(3):220-32. doi: 10.2165/00002018-199410030-00004.

Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi.选择性和非选择性β-肾上腺素能拮抗剂塞利洛尔、比索洛尔和普萘洛尔对人支气管的药理作用。

Br J Pharmacol. 1994 Nov;113(3):1043-9. doi: 10.1111/j.1476-5381.1994.tb17098.x.

Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.塞利洛尔。对其药效学、药代动力学特性及其在高血压和心绞痛治疗中的应用的初步综述。

Drugs. 1987 Oct;34(4):438-58. doi: 10.2165/00003495-198734040-00002.

Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.塞利洛尔、普萘洛尔、氧烯洛尔和阿替洛尔对慢性阻塞性肺疾病高血压患者呼吸功能的比较影响。

Cardiovasc Drugs Ther. 1990 Aug;4(4):1145-9. doi: 10.1007/BF01856511.

Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.塞利洛尔：对其药效学、药代动力学特性及在心血管疾病中治疗效果的最新综述。

Drugs. 1991 Jun;41(6):941-69. doi: 10.2165/00003495-199141060-00009.

Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.对具有血管舒张特性的新型心脏选择性β1肾上腺素能阻滞剂塞利洛尔治疗老年人轻至中度高血压的评估。

Cardiovasc Drugs Ther. 1991 Jan;4 Suppl 6:1291-5. doi: 10.1007/BF00114236.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验